NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.

NeuroPace, Inc.

Valsight provides software for data-based strategic decision-making, enabling complex scenario simulations in corporate performance management.

Valsight

NeuroPace develops and offers the RNS System, an FDA-approved device for the personalized treatment of drug-resistant focal epilepsy, providing insights into seizure trends and triggers.

Metric
Company Name	NeuroPace, Inc.	Valsight
Symbol	NPCE
MSH ID	COM:NEUROPACE	COM:VALSIGHT
Market	STOCKS	PRIVATE
Sector	Healthcare	Technology
Industry	Medical - Devices	Software
Country	US	DE
Stage		Seed
Employee Count	181
Website	neuropace.com	valsight.com
LinkedIn
Founders

Metric
Market Cap	197.64M
Enterprise Value
Monthly Web Traffic		979
Web Traffic Growth		-1.00
Valuation
Raised Capital

Metric
Revenue	65.42M
Revenue (LTM)
Revenue (NTM)
Gross Profit	48.12M
EBITDA	-25.57M
Operating Income	-27.17M
Net Income	-32.96M
EPS	-1.27
Diluted EPS	-1.27
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.74
Operating Profit Margin	-0.34
EBITDA Margin	-0.39
Net Profit Margin	-0.33
Return on Equity	-1.24
Return on Assets	-0.23
Return on Capital Employed	-0.30

COM:NEUROPACE

NeuroPace

Last Close

9.00

22/11 21:00

Market Cap

197.64M

Beta: -

Volume Today

67.03K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-9.27
P/B Ratio	24.47
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	6.13
EV Multiple	-5.04

Metric
Days Sales Outstanding	68.39
Days Payables Outstanding	26.20
Days Inventory Outstanding	236.61
Operating Cycle	305.31
Cash Conversion Cycle	256.11
Asset Turnover	0.76

Metric
Operating Cash Flow	-19.70M
Free Cash Flow	-19.87M
Cash Flow to Debt	-0.24
Operating Cash Flow/Sales	-0.24
Free Cash Flow Yield	-0.06

Metric
Cash & Equivalents	18.06M
Accounts Receivable	-4.85M
Inventory	11.21M
Goodwill
Debt to Capitalization	0.86
Debt to Assets	0.72
Current Ratio	6.55
Quick Ratio	5.56

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.15
R&D to Revenue	0.34
SG&A to Revenue